Amid significant legislative advancements, Johnson & Johnson (J&J) embarks on a pivotal journey to transform the pharmaceutical manufacturing landscape in the United States. By committing a staggering $55 billion towards domestic production initiatives, J&J aims to shed reliance on international
Kwame Zaire, known for his profound expertise in the manufacturing sector with a special focus on electronics and equipment, is a thought leader passionate about predictive maintenance, quality, and safety. In this insightful conversation, Kwame delves into the critical expansion of Piramal
In the past several years, the United States has witnessed a remarkable surge in investments from pharmaceutical giants as they seek to expand drug manufacturing facilities on American soil. This ambitious shift is largely influenced by geopolitical uncertainties and evolving market dynamics. A
The recent wave of investments by major biotech companies into U.S. manufacturing capabilities marks a pivotal movement, reshaping the landscape of the pharmaceutical industry. These corporations are strategically enhancing domestic production to mitigate risks associated with global supply chains
Stevanato Group’s strategic expansion into the U.S. with a significant investment in syringe production marks a pivotal moment in the biopharmaceutical landscape. Located in Fishers, Indiana, this Italian company has strategically aligned itself with the growing demands of biologics, making notable
In this insightful discourse, we have the privilege of speaking with Kwame Zaire, a renowned expert in manufacturing with a keen focus on the electronics and equipment industry. Kwame brings a wealth of knowledge on production management, predictive maintenance, quality, and safety. Today, we delve
